Alimera Sciences (ALIM) Earnings

In its last earnings report on October 24, 2024, Alimera Sciences reported earnings per share (EPS) of $-0.06, compared to an estimated EPS of $-0.01. The company reported revenue of $-, compared to an estimated revenue of $27.44M.

Alimera Sciences's current Price-to-Earnings (P/E) ratio is -5.49. The trailing twelve months (TTM) P/E ratio is -20.50. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.

For the fiscal year ending December 31, 2023, Alimera Sciences reported total revenue of $80.75M and net income of $-20.13M. This represents a net profit margin of -0.2493003443.

Alimera Sciences's earnings yield is -18.23%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.

Alimera Sciences's return on equity (ROE) is -43.60%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.

Alimera Sciences's gross profit margin is 75.70%. This indicates that for every dollar of revenue, the company retains $0.76 as gross profit after accounting for the cost of goods sold.